Seviteronel
CAS: 1610537-15-9
Ref. TM-T13312L
| 1mg | 109.00 € | ||
| 5mg | 253.00 € | ||
| 10mg | 361.00 € | ||
| 25mg | 616.00 € | ||
| 50mg | 874.00 € | ||
| 100mg | 1,167.00 € |
Estimated delivery in United States, on Monday 10 Mar 2025
Product Information
Name:
Seviteronel
Synonyms:
- VT-464
- (αS)-α-[6,7-Bis(difluoromethoxy)-2-naphthalenyl]-α-(1-methylethyl)-1H-1,2,3-triazole-5-methanol
- (1S)-1-[6,7-Bis(difluoromethoxy)naphthalen-2-yl]-2-methyl-1-(2H-triazol-4-yl)propan-1-ol
- 1H-1,2,3-Triazole-5-methanol, α-[6,7-bis(difluoromethoxy)-2-naphthalenyl]-α-(1-methylethyl)-, (αS)-
- VT 464
Description:
Seviteronel (VT-464) is a novel CYP17 cleavage enzyme inhibitor and androgen receptor antagonist for the study of breast and prostate cancer.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
399.34
Formula:
C18H17F4N3O3
Purity:
100% - 99.98%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T13312L Seviteronel
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
